pentagastrin has been researched along with Minimal Disease, Residual in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attard, M; Bianchi, D; Costante, G; Crocetti, U; Durante, C; Filetti, S; Maranghi, M; Meringolo, D; Nocera, M; Torlontano, M; Tumino, S | 1 |
| Cohnen, M; Cupisti, K; Eisenberger, CF; Knoefel, WT; Nguyen, TB; Sagert, C; Scherbaum, WA; Schinner, S; Schott, M; Willenberg, HS | 1 |
2 other study(ies) available for pentagastrin and Minimal Disease, Residual
| Article | Year |
|---|---|
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chemistry, Clinical; Child; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Pentagastrin; Predictive Value of Tests; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule | 2007 |
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Topics: Adult; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Humans; Luminescence; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm, Residual; Pentagastrin; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy | 2007 |